Jinyan Lv
The Key Laboratory Of Biomarker High Throughput Screening And Target Translation Of Breast And Gastrointestinal Tumor
Dalian, 116001, China
Dalian, 116001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Novel strategy for comprehensive therapy with sustainably complete response in a patient with limited-stage small cell lung cancer: a case report.
Journal: The Journal of international medical research
Published: December 24, 2024
Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources.
Journal: Experimental hematology & oncology
Published: September 13, 2024
Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Journal: The Journal of international medical research
Published: January 08, 2024
Anti-γ-Aminobutyric Acid Type β Receptor Antibody-Associated Encephalitis After 2 Cycles of Durvalumab Therapy in a Patient with Small Cell Lung Cancer: A Case Report.
Journal: OncoTargets and therapy
Published: September 09, 2021
Case Report: Vemurafenib Treatment in Brain Metastases of BRAFS365L -Mutant Lung Papillary Cancer by Genetic Sequencing of Cerebrospinal Fluid Circulating Tumor DNA Detection.
Journal: Frontiers in oncology
Published: March 30, 2021
The prognostic role of a combined fibrinogen and inflammation-based index in patients with metastatic breast cancer.
Journal: Translational cancer research
Published: May 22, 2020
Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients.
Journal: Translational cancer research
Published: May 08, 2020
Effective Treatment with Cabozantinib in an Advanced Non-Small-Cell Lung Cancer Patient Harboring a CD74-ROS1 Fusion: A Case Report.
Journal: OncoTargets and therapy
Published: October 15, 2019
Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report.
Journal: OncoTargets and therapy
Published: September 21, 2018
Two functional polymorphisms in microRNAs and lung cancer risk: a meta-analysis.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: September 29, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026